VEGFA and Patent ductus arteriosus: Since these MMF-treated PDA tumors decreased vascular endothelial growth factor (VEGF) synthesis and secretion, the results suggested that there is likely a genetic factor(s) or cellular context that renders the PDA tumor susceptible to MMF.